Phase I/II Trial of Melphalan Prednisone Plus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Stem Cell Transplant.
Phase of Trial: Phase I/II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Lenalidomide (Primary) ; Melphalan (Primary) ; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 04 Jan 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 23 Jul 2008 Status changed from recruiting to in progress, from clinicaltrials.gov record.